Hepatitis C: Home Page

<body><!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head><link rel="stylesheet" media="print" href="https://www.ark.org/siteheader/print.css" type="text/css" /> <style type="text/css"> @media print { #banner, #topnav, #logo, #empty, #arlogo, .noprint { display: none; } } @media screen { #banner { margin-top:0px; margin-left:0px; margin-right:0px; } } </style> <style type="text/css"> body {font-size:100%; margin:0px; padding:0px;} #banner{ background-color: #FFFFFF; width: 100%; height: 30px; border-bottom: 1px solid #747A7C; padding:0px; margin:0px;} #topnav{ margin-top:-18px; font-family: Arial; text-align:right; color: #747A7C; background-color: transparent; font-size: 11px; position:relative; text-decoration:none; font-weight: bold; padding-right:10px;} #topnav a:link { text-align:right; color: #747A7C; background-color: transparent; font-size: 11px; text-decoration:none;} #topnav a:visited {text-align:right; color: #747A7C; background-color: transparent; font-size: 11px; text-decoration:none;} #topnav a:hover { text-align:right; color: #747A7C; background-color: transparent; font-size: 11px; text-decoration:underline;} #topnav a:active { text-align:right; color: #747A7C; background-color: transparent; font-size: 11px;text-decoration:none;} #logo { background-color: #FFFFFF; width:100px; height:25px; position:relative; margin:0px; padding-left:10px; padding-top:4px; padding-bottom:-3px; } #empty{ height: 3px; width: auto;} </style> </head> <body topmargin="0" leftmargin="0" bottommargin="0"><div id="banner"><div id="logo"><a href="http://www.arkansas.gov"><img src="https://www.ark.org/siteheader/argovlogo_v2.gif" alt="Arkansas.gov" width="106" height="25" border="0"></a></div></div><div id="topnav"><a href="http://www.arkansas.gov/government_name.php">Agencies</a> | <a href="http://www.arkansas.gov/online_services_alpha.php">Online Services</a> | <a href="http://www.arkansas.gov/ina_policy.php">Policies</a></div></div> <div id="empty"> </div></body> </html> <table border="0" cellpadding="5" cellspacing="0" width="555"> <tr> <td> <div ><table border="0" cellspacing="0" cellpadding="0" bgcolor="#FFFFFF" width="555"> <tr> <td valign="top" colspan="2"><img src="../graphics/09_testing.jpg" alt="Hepatitis C: Testing for HCV Infection" width="555" height="70"></td> </tr> <tr> <td valign="bottom"> <p><img border="0" src="../graphics/spacer.gif" width="121" height="4"></p> </td> <td valign="top"> <p ><font face="Verdana, Arial, Helvetica"><br> <font size="2"> Consent for testing should be obtained in a manner consistent with that for other medical care and services provided in the same setting, and should include measures to prevent unwanted disclosure of test results to others.  Persons should be provided with information regarding</font></font><ul style="color: rgb(70,88,142)" type="square"> <li style="color: rgb(70,88,142)"> <p ><font color="#000000" face="Verdana, Arial, Helvetica" size="2">exposures associated with the transmission of HCV, including behaviors or exposures that might have occurred infrequently or many years ago;</font></li> <li> <p ><font color="#000000" face="Verdana, Arial, Helvetica" size="2">the test procedures and the meaning of test results; the nature of hepatitis C and chronic liver disease;</font></li> <li> <p ><font color="#000000" face="Verdana, Arial, Helvetica" size="2">the benefits of detecting infection early;</font></li> <li> <p ><font color="#000000" face="Verdana, Arial, Helvetica" size="2">available medical treatment; and</font></li> <li> <p ><font color="#000000" face="Verdana, Arial, Helvetica" size="2">potential adverse consequences of testing positive, including disrupted personal relationships and possible discriminatory action (e.g., loss of employment, insurance, and educational opportunities).</font></li> </ul> <p ><font face="Verdana, Arial, Helvetica" size="2">Comprehensive information regarding hepatitis C should be provided before testing; however, this might not be practical when HCV testing is performed as part of a clinical work-up or when testing for anti-HCV is required.  In these cases, persons should be informed that a) testing for HCV infection will be performed, b) individual results will be kept confidential, and c) appropriate counseling and referral will be offered if results are positive.</font></p> <p ><font face="Verdana, Arial, Helvetica" size="2">Testing for HCV infection can be performed in various settings, including physicians' offices, other health-care facilities, health department clinics, and HIV or other freestanding counseling and testing sites. Such settings should be prepared to provide appropriate information regarding hepatitis C and provide or offer referral for additional medical care or other needed services (e.g., drug treatment), as warranted. Facilities providing HCV testing should have access to information regarding referral resources, including availability, accessibility, and eligibility criteria of local medical care and mental health professionals, support groups, and drug-treatment centers.</font></p> <p ><font face="Verdana, Arial, Helvetica" size="2"> The diagnosis of HCV infection can be made by detecting either anti-HCV or HCV RNA. Anti-HCV for routine testing of asymptomatic persons should include both EIA to test for anti-HCV and supplemental or confirmatory testing with an additional, more specific assay. (Figure 3.) Use of supplemental antibody testing (i.e., RIBA<sup>™</sup>) for all positive anti-HCV results by EIA is preferred, particularly in settings where clinical services are not provided directly. </font></p> </td> </tr> <tr> <td valign="bottom" colspan="2"> <p align="right"><a href="figure_3_1.PDF"><img border="0" src="../graphics/figure3.jpg" alt="click here to open PDF file" width="431" height="398"></a> </td> </tr> <tr> <td valign="top">  </td> <td valign="top"> <p ><font face="Verdana, Arial, Helvetica" size="2">Supplemental anti-HCV testing confirms the presence of anti-HCV (i.e., eliminates false-positive antibody results), which indicates past or current infection, and can be performed on the same serum sample collected for the EIA (i.e., routine serology). Confirmation or exclusion of HCV infection in a person with indeterminate anti-HCV supplemental test results should be made on the basis of further laboratory testing, which might include repeating the anti-HCV in two or more months or testing for HCV RNA and ALT level.</font></p> <p ><font face="Verdana, Arial, Helvetica" size="2"> In clinical settings, use of RT-PCR to detect HCV RNA might be appropriate to confirm the diagnosis of HCV infection (e.g., in patients with abnormal ALT levels or with indeterminate supplemental anti-HCV test results) although RT-PCR assays are not currently FDA-approved.  Detection of HCV RNA by RT-PCR in a person with an anti-HCV-positive result indicates current infection.  However, absence of HCV RNA in a person with an anti-HCV-positive result based on EIA testing alone (i.e., without supplemental anti-HCV testing) cannot differentiate between resolved infection and a false-positive anti-HCV test result. In addition, because some persons with HCV infection might experience intermittent viremia, the meaning of a single negative HCV RNA result is difficult to interpret, particularly in the absence of additional clinical information. If HCV RNA is used to confirm anti-HCV results, a separate serum sample will need to be collected and handled in a manner suitable for RT-PCR.  If the HCV RNA result is negative, supplemental anti-HCV testing should be performed so that the anti-HCV EIA result can be interpreted before the result is reported to the patient.</font></p> <p ><font face="Verdana, Arial, Helvetica" size="2">Laboratories that perform HCV testing should follow the recommended anti-HCV testing algorithm, which includes use of supplemental testing. Having assurances that the HCV testing is performed in accredited laboratories whose services adhere to recognized standards of good laboratory practice is also necessary. Laboratories that perform HCV RNA testing should review routinely their data regarding internal and external proficiency testing because of great variability in accuracy of HCV RNA testing.</font></p> <p align="left"><a href="javascript:pp()"><img src="../graphics/pp/0_patient_per3.jpg" alt="patient perspective" border="0" width="422" height="111"></a> </p> <a href="javascript:sq()"><img src="../graphics/question_click.jpg" alt="study question" align="left" border="0" width="421" height="50"> </a> <p>  <p>  </td> </tr> <tr> <td valign="top">  </td> <td valign="top">  </td> </tr> <tr> <td valign="top">  </td> <td valign="top"> <div align="right"> <table border="0" cellpadding="2" cellspacing="0"> <tr> <td nowrap><a href="javascript:history.go(-1);back()"><img border="0" src="../graphics/back.jpg" alt="BACK" width="42" height="29"></a><img border="0" src="../graphics/fill.jpg" width="56" height="29"><img border="0" src="../graphics/open.jpg" width="12" height="29"><a href="../8/default.htm" target="_top"><img border="0" src="../graphics/next.jpg" alt="NEXT" width="45" height="29"></a></td> </tr> </table> </div> </td> </tr> </table> </div> </td> </tr> </table> </body>